SupplementsProactive HealthGLP-1 Adapting Appetites
Meet the GLP-1 Consumers Driving Impact in Supplements

ADAPTING APPETITES

SUPPORTed by
SUPPLEMENTS
Scroll to explore
Growing GLP-1 Obsession

FROM NICHE, TO NORM.

GLP-1’s are replacing ‘going on a diet’ as the preferred weight loss quick fix.

Find out how this is presenting a huge opportunity for supplement choices to adapt their appeal along the GLP-1 user journey, as users focus on losing, and then maintaining their weight.

The GLP-1
User Lifecycle:
What to Expect

Our latest whitepaper draws on proprietary research from over 2,600 U.S. adults to explore how GLP-1 treatments are reshaping consumer behavior.

Examining the Before, During, and After,
this research helps the supplement industry navigate shifting demand, preferences, and eating habits in an evolving market.

BEFORE

Consideration Phase

Individuals turn to GLP-1 for different
reasons, from managing weight to
controlling diabetes.

77% seek weight loss and appetite control,
while 23% use it for diabetes management,
spanning all age groups.

Many have faced lifelong struggles
with weight, highlighting the diverse
motivations behind starting this treatment.

DURING

Active Phase

While GLP-1 medications appear to offer
significant benefits, many users face
gastrointestinal side effects.

Around ¼ users experience GI discomfort, with
35% reporting nausea, 24% experiencing
diarrhea, and 22% suffering from
constipation

Rapid weight loss can also lead to lean
muscle loss. Supporting gut health,
possibly with probiotics, may help
improve user experience.

AFTER

Maintenance Phase

Maintaining weight loss after GLP-1
treatment is a growing concern. After
stopping weekly semaglutide (2.4 mg),
users regained two-thirds of lost
weight, with similar cardiometabolic
changes.

42% of consumers seek products to
sustain results. As obesity is now
recognized as a chronic disease, long-term
management solutions are
essential.

This website is intended to provide business-to-business information. The information and statements herein are for example only and products and claims may not be approved in your region. The information and statements herein must be reviewed for compliance with applicable local laws. Please check with your local account representative to inquire about market clearance and claims approved for your region.

Nothing in this web site is intended to be an offer which is capable of acceptance and/or inducement of any kind. Descriptions of, or references or access to other publications within the web site do not imply endorsement of those publications. This web site could contain technical inaccuracies, and changes to the information contained herein may be made at any time without notice.

Kerry Group P.L.C. (including its associate and subsidiary companies) neither makes nor gives any warranty of any kind with respect to any subject matter or information included in, or for the completeness or accuracy, of this web site. Kerry Group P.L.C. is not responsible for any actions (or lack thereof) taken as a result of relying on or in any way using information contained in this website and in no event shall it be liable for any damages resulting from reliance on or use for any purpose of this information. Without limiting the above, Kerry Group P.L.C. shall have no responsibility for any act or omission of any other contributor.